Repligen (RGEN) Amortization of Deferred Charges (2021 - 2026)
Repligen's (RGEN) quarterly Amortization of Deferred Charges came in at $4.8 million in Q1 2026, up 18.22% year-on-year from $4.0 million in Q1 2025, and up 11.41% on a QoQ basis from $4.3 million in Q4 2025.
Repligen (RGEN) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends
Repligen (RGEN) has 6 years of Amortization of Deferred Charges data on file, last reported at $4.8 million in Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges rose 18.22% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $17.1 million, a 30.77% decrease from a year earlier, with the FY2025 full-year figure at $16.6 million, up 6.79% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $4.8 million, up from $4.3 million in the prior quarter.
- Over the last five years, Amortization of Deferred Charges for RGEN reached as high as $16.2 million in Q4 2023 and fell as low as -$1.4 million in Q4 2022.
- Historically, Amortization of Deferred Charges has averaged $2.9 million across 5 years, with a median of $458000.0 in 2023.
- Across the five-year window, Amortization of Deferred Charges tumbled 619.08% in 2022 and surged 1290.07% in 2023, its largest moves.
- Year by year, Amortization of Deferred Charges stood at -$1.4 million in 2022, then jumped by 1290.07% to $16.2 million in 2023, then slumped by 75.53% to $4.0 million in 2024, then increased by 8.23% to $4.3 million in 2025, then climbed by 11.41% to $4.8 million in 2026.
- Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $4.8 million in Q1 2026, $4.3 million in Q4 2025, and $4.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Repligen | 7.37 Bn | 6.39 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.78 Mn |
| Mar 31, 2026 | 4.78 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Dec 31, 2025 | 4.29 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Dec 31, 2024 | 3.96 Mn |
| Dec 31, 2023 | 16.19 Mn |
| Dec 31, 2023 | 16.19 Mn |
| Sep 30, 2023 | 459,000.00 |
| Sep 30, 2023 | 459,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 457,000.00 |
| Mar 31, 2023 | 457,000.00 |
| Dec 31, 2022 | -1.36 Mn |
| Dec 31, 2022 | -1.36 Mn |
| Sep 30, 2022 | 455,000.00 |
| Sep 30, 2022 | 455,000.00 |